Metagenomi taps Amazon's custom chips to develop gene-editing tools

Core Insights - Metagenomi is leveraging artificial intelligence chips from Amazon's cloud computing division to enhance its gene-editing technology development [1] Company Summary - Metagenomi is a biotech firm focused on developing gene-editing technologies [1] - The company is utilizing advanced AI capabilities provided by Amazon to support its research and development efforts [1] Industry Summary - The integration of AI in biotech, particularly in gene editing, signifies a growing trend in the industry towards utilizing cloud computing resources for enhanced research capabilities [1]